Similarly, PVT1 could bind epigenetic modification complexes (PRC2) for histone methylation in the promoter of ANGPTL4, and thus, promote the malignancy of Cholangiocarcinoma [30]. This evidence concerns the gene PVT1 and cholangiocarcinoma.